1. Home
  2. KYTX vs NRDY Comparison

KYTX vs NRDY Comparison

Compare KYTX & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • NRDY
  • Stock Information
  • Founded
  • KYTX 2018
  • NRDY 2007
  • Country
  • KYTX United States
  • NRDY United States
  • Employees
  • KYTX N/A
  • NRDY N/A
  • Industry
  • KYTX
  • NRDY Computer Software: Prepackaged Software
  • Sector
  • KYTX
  • NRDY Technology
  • Exchange
  • KYTX NYSE
  • NRDY Nasdaq
  • Market Cap
  • KYTX 196.4M
  • NRDY 220.5M
  • IPO Year
  • KYTX 2024
  • NRDY N/A
  • Fundamental
  • Price
  • KYTX $3.98
  • NRDY $1.71
  • Analyst Decision
  • KYTX Buy
  • NRDY Hold
  • Analyst Count
  • KYTX 5
  • NRDY 8
  • Target Price
  • KYTX $23.20
  • NRDY $2.35
  • AVG Volume (30 Days)
  • KYTX 453.0K
  • NRDY 3.4M
  • Earning Date
  • KYTX 02-12-2025
  • NRDY 11-07-2024
  • Dividend Yield
  • KYTX N/A
  • NRDY N/A
  • EPS Growth
  • KYTX N/A
  • NRDY N/A
  • EPS
  • KYTX N/A
  • NRDY N/A
  • Revenue
  • KYTX N/A
  • NRDY $197,325,000.00
  • Revenue This Year
  • KYTX N/A
  • NRDY N/A
  • Revenue Next Year
  • KYTX N/A
  • NRDY $2.86
  • P/E Ratio
  • KYTX N/A
  • NRDY N/A
  • Revenue Growth
  • KYTX N/A
  • NRDY 9.55
  • 52 Week Low
  • KYTX $3.63
  • NRDY $0.73
  • 52 Week High
  • KYTX $30.60
  • NRDY $3.60
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 38.40
  • NRDY 60.30
  • Support Level
  • KYTX $3.63
  • NRDY $1.46
  • Resistance Level
  • KYTX $4.60
  • NRDY $2.18
  • Average True Range (ATR)
  • KYTX 0.45
  • NRDY 0.26
  • MACD
  • KYTX -0.10
  • NRDY -0.01
  • Stochastic Oscillator
  • KYTX 8.58
  • NRDY 39.87

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.

Share on Social Networks: